Get the Stockscreener App
107.56
1.00%
1.07
After Hours:
108.10
0.54
+0.50%
Vaxcyte Inc stock is traded at $107.56, with a volume of 692.85K.
It is up +1.00% in the last 24 hours and down -3.35% over the past month.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
See More
Previous Close:
$106.49
Open:
$105.18
24h Volume:
692.85K
Relative Volume:
0.77
Market Cap:
$13.31B
Revenue:
-
Net Income/Loss:
$-436.82M
P/E Ratio:
-27.75
EPS:
-3.876
Net Cash Flow:
$-482.56M
1W Performance:
+1.89%
1M Performance:
-3.35%
6M Performance:
+63.07%
1Y Performance:
+111.94%
1-Day Range:
$104.06
$108.40
1-Week Range:
$103.07
$109.30
52-Week Range:
$46.16
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
Name
Vaxcyte Inc
Sector
Industry
Phone
650-837-0111
Address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-07-23 | Initiated | Mizuho | Buy |
| Apr-18-23 | Initiated | TD Cowen | Outperform |
| Jan-03-23 | Reiterated | Needham | Buy |
| Dec-15-22 | Initiated | Guggenheim | Buy |
| Nov-17-22 | Initiated | BTIG Research | Buy |
| Dec-29-21 | Resumed | Jefferies | Buy |
| Jun-24-21 | Resumed | Jefferies | Buy |
| Jul-07-20 | Initiated | BofA Securities | Buy |
| Jul-07-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-07-20 | Initiated | Needham | Buy |
View All
Vaxcyte Inc Stock (PCVX) Latest News
Vaxcyte Inc (PCVX) Reports Q3 2024 Net Loss of $103.1 Million Am - GuruFocus.com
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Vaxcyte, Inc. (NASDAQ:PCVX) COO Jim Wassil Sells 8,000 Shares - MarketBeat
Vaxcyte COO Jim Wassil sells $854k in stock - Investing.com
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million - Investing.com
Harbor Capital Advisors Inc. Has $7.39 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Should You Consider Investing in Vaxcyte (PCVX)? - Insider Monkey
Raymond James & Associates Buys 11,798 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte’s stock flat as biotech preps to complete $1.42 billion stock offering - MSN
Vaxcyte (NASDAQ:PCVX) Trading Down 5.9%Time to Sell? - MarketBeat
China Universal Asset Management Co. Ltd. Grows Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Novo Holdings A S Has $85.70 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Creative Planning Buys 10,245 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte stock holds $160 target with Buy rating from BTIG By Investing.com - Investing.com Canada
Moody Aldrich Partners LLC Trims Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
How To Trade (PCVX) - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Receives $147.50 Average Price Target from Brokerages - MarketBeat
Vaxcyte's president and CFO sells $4.8 million in shares - Investing.com
Vaxcyte's president and CFO sells $4.8 million in shares By Investing.com - Investing.com Canada
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells 42,000 Shares of Stock - MarketBeat
Taking on analysts’ expectations and winning: Vaxcyte Inc (PCVX) - SETE News
Taking A Shot At Vaxcyte - RTTNews
(PCVX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
PCVX Stock Sees Surge of Approximately 0.47% in Last Five Days - Knox Daily
Vaxcyte shares rise on bullish analyst outlook By Investing.com - Investing.com Canada
SG Americas Securities LLC Has $1.09 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte shares rise on bullish analyst outlook - Investing.com
Vaxcyte CEO Grant Pickering sells over $775k in company stock - Investing.com India
Vaxcyte CEO Grant Pickering sells over $775k in company stock By Investing.com - Investing.com South Africa
Biotech may have a cash crunch but these Bay Area companies still have fat wallets - The Business Journals
Vaxcyte executive sells over $546k in company stock By Investing.com - Investing.com Canada
Vaxcyte, Inc. (NASDAQ:PCVX) SVP Sells 5,000 Shares - MarketBeat
Vaxcyte CEO Grant Pickering sells shares worth over $775,000 By Investing.com - Investing.com South Africa
Vaxcyte executive sells over $546k in company stock - Investing.com India
Creative Planning Purchases 10,642 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Clearbridge Investments LLC Makes New $14.06 Million Investment in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
The Manufacturers Life Insurance Company Purchases 12,667 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte SVP sells over $628k in company stock - Investing.com India
Vaxcyte SVP sells over $628k in company stock By Investing.com - Investing.com Australia
Vaxcyte CEO sells over $6.2 million in company stock - Investing.com India
Vaxcyte CEO sells over $6.2 million in company stock By Investing.com - Investing.com Australia
Vaxcyte Inc (PCVX) is a good investment, but the stock may be undervalued - US Post News
Vaxcyte stock soars 35% on promising VAX-31 vaccine trial results - MSN
Envestnet Asset Management Inc. Has $3.62 Million Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Algert Global LLC Buys 21,442 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte Inc Stock (PCVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vaxcyte Inc Stock (PCVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wassil Jim | CHIEF OPERATING OFFICER |
Nov 01 '24 |
Option Exercise |
2.42 |
8,000 |
19,360 |
213,695 |
| Wassil Jim | CHIEF OPERATING OFFICER |
Nov 01 '24 |
Sale |
106.80 |
8,000 |
854,423 |
205,695 |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):